Paradigm Medical Industries, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PDMI research report →
Companywww.paradigm-medical.com
Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters.
- CEO
- Charles S. Pritchard
- IPO
- 1996
- Employees
- 5
- HQ
- Salt Lake City, UT, US
Price Chart
Valuation
- Market Cap
- $324.88K
- P/E
- -0.01
- P/S
- 0.42
- P/B
- -0.00
- EV/EBITDA
- -7.65
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 68.01%
- Op Margin
- 42.75%
- Net Margin
- -61.40%
- ROE
- 19.31%
- ROIC
- -105.10%
Growth & Income
- Revenue
- $772.00K · 6.34%
- Net Income
- $-474,000 · 51.03%
- EPS
- $-0.01 · 50.96%
- Op Income
- $330.00K
- FCF YoY
- 38.79%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -76.24
- Avg Volume
- 7.40M
Get TickerSpark's AI analysis on PDMI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PDMI Coverage
We haven't published any research on PDMI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PDMI Report →